Moved Cash Into Treasury Bills; Social Security Tax Torpedo
A growing number of retirees moved cash into Treasury bills to lock in near-4% yields. But the tax system on Social S...
Investing
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
17,689 articlesArm Holdings Near $347? Case for Double-Digit Upside
Arm Holdings trades around $347 as investors weigh AI-driven demand and data-center opportunities. Analysts see a pat...
FuelCell Energy Drops 10% as Profit-Taking Hits Sector
FuelCell Energy leads a sell-off in fuel-cell stocks as investors lock in gains after a sharp rally, while Bloom Ener...
Apple Quietly Hiking Prices: Mac and IPad Signals Next Move
Apple quietly hiking prices on Mac and iPad models signals a shift in pricing strategy as memory costs rise, with inv...
A Rare Dividend Stock Built to Weather Recession Storms
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
Can’t Afford Retirement Napa? Consider Paso Robles Now
Rising costs in Napa Valley are squeezing retirees. This report spotlights Paso Robles as a lower-cost alternative th...
We're Just Weeks Away: Medicare GLP-1 Coverage at $50
A new Medicare bridge program could lower GLP-1 drug bills to about $50 a month for eligible seniors. Here’s what you...
Citigroup Wells Fargo: Which Stock Is a Better Buy in 2026?
Citigroup and Wells Fargo chart different paths: one leans global and institutional, the other domestic and consumer-...
Micron After Blowout Earnings: Is It a Buy Now?
Micron Technology rides the AI memory wave, but a blowout earnings report invites questions. This guide breaks down t...
Nano Nuclear Energy Nuscale: Which Stock to Buy in 2026
Two bold players are redefining nuclear power. This guide compares Nano Nuclear Energy Nuscale and NuScale Power, unp...
This Might Cheapest Meta Trades: Why Now Could Be It
Meta Platforms looks cheaper than it has in years, with growth signals that could power a turnaround by 2027. This gu...
Analyst Just Declared Lilly the Clear Winner at ADA Conference
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...